Dec 8, 2016
Stanford GSB Impact Fund Bridges Classroom and Workforce
Stanford’s Graduate School of Business recently published an article by Margaret Steen about the first investment made by the Stanford GSB Impact Fund in Geneticure, a pharmocogenetic testing company “working on a better diagnostic test for hypertension [to] quickly identify which treatment will work best for which patient.”
Continue reading…
